Neighbourly Pharmacy Inc. (TSE:NBLY – Get Free Report) has been assigned a consensus rating of “Hold” from the five research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is C$20.93.
A number of research analysts have recently commented on NBLY shares. National Bankshares lowered their target price on Neighbourly Pharmacy from C$20.50 to C$18.50 and set a “tender” rating for the company in a research note on Monday, January 15th. TD Securities downgraded shares of Neighbourly Pharmacy from an “outperform” rating to a “sector perform” rating and reduced their target price for the stock from C$28.00 to C$18.50 in a research report on Wednesday, February 14th. Finally, Desjardins dropped their price objective on shares of Neighbourly Pharmacy from C$20.00 to C$18.50 and set a “hold” rating on the stock in a research note on Wednesday, February 14th.
Read Our Latest Research Report on Neighbourly Pharmacy
Insider Buying and Selling at Neighbourly Pharmacy
Neighbourly Pharmacy Trading Up 0.3 %
TSE:NBLY opened at C$18.60 on Friday. The firm has a market capitalization of C$835.51 million, a P/E ratio of -25.48 and a beta of 0.29. Neighbourly Pharmacy has a 52 week low of C$12.05 and a 52 week high of C$23.00. The company has a quick ratio of 0.75, a current ratio of 1.14 and a debt-to-equity ratio of 58.29. The company has a fifty day moving average of C$18.46 and a 200 day moving average of C$17.52.
About Neighbourly Pharmacy
Neighbourly Pharmacy Inc owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading.
Further Reading
- Five stocks we like better than Neighbourly Pharmacy
- Find and Profitably Trade Stocks at 52-Week Lows
- Garmin Navigates to New Highs Driven By Wearables Trend
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Use the MarketBeat Stock Screener
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Neighbourly Pharmacy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neighbourly Pharmacy and related companies with MarketBeat.com's FREE daily email newsletter.